This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent. Top assignee: Transtech Pharma, Inc.. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Susanna Roe: Innovator in RAGE Fusion Protein Glycosylation
Introduction
Susanna Roe is a notable inventor based in Wentzville, MO (US). She has made significant contributions to the field of biotechnology, particularly in the area of RAGE fusion proteins. Her innovative work has led to the development of methods for controlling the glycosylation of these proteins, which is crucial for their functionality and therapeutic potential.
Latest Patents
Susanna Roe holds 1 patent for her invention titled "Control of RAGE fusion protein glycosylation and RAGE fusion protein compositions." This invention relates to methods for controlling the glycosylation of a RAGE fusion protein. It also includes compositions that contain a specific amount of a RAGE fusion protein, where at least 0.5% of the protein is aglycosylated, and no more than 53.2% of the protein is aglycosylated. This work has important implications for the development of therapeutic proteins.
Career Highlights
Throughout her career, Susanna has worked with various companies, including Transtech Pharma, Inc. and Vtv Therapeutics LLC. Her experience in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in biotechnology.
Collaborations
Some of her notable coworkers include Rodney G Combs and Derrick L Ruble. Their collaboration has likely fostered an environment of innovation and creativity, leading to significant advancements in their respective fields.
Conclusion
Susanna Roe's contributions to the field of RAGE fusion proteins exemplify the impact of innovative thinking in biotechnology. Her work not only advances scientific understanding but also holds promise for future therapeutic applications.